| 查看: 712 | 回复: 2 | ||
jinmei7020金虫 (初入文坛)
|
[求助]
求美国药典USP35版 aspirin enteric-coated tablets的质量标准
|
|
哪位大侠能不能帮我查下美国药典USP35版aspirin enteric-coated tablets的质量标准，邮箱是zhangmei8402@163.com，谢谢！！！ [ Last edited by jinmei7020 on 2012-8-15 at 14:14 ] |
回复此楼» 猜你喜欢
让我中一个面上吧！
已经有15人回复
-
2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战
已经有5人回复
-
跳槽后在研项目怎么办？
已经有10人回复
-
什么时候开奖？
已经有10人回复
-
2026国自然函评费到账
已经有16人回复
-
今天放榜吗？
已经有16人回复
-
93BebMhtakh前后11位开头都是大写
已经有8人回复
-
范进中举一文的中心思想
已经有4人回复
-
只有每年这种时候来逛逛小木虫
已经有26人回复
-
filecode，4个jtjc了
已经有16人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 仿制药质量标准的制定
已经有12人回复
- 求高人赐教：我是一名食品质量与安全专业的本科生，请问ISO与我们专业的种种得失
已经有16人回复
- 求助关于质量标准有关物质问题
已经有15人回复
- 【求助】怎么在美国药典查中药标准？
已经有7人回复
- 【求助】求助Aprepitant 的美国药典质量标准
已经有6人回复
- 【求助】如何测定硫酸钙、硫化钙和氧化钙混合物中各组分的质量分数
已经有4人回复
- 关于美国药典的疑问
已经有4人回复
泡泡-211
至尊木虫 (知名作家)
- PhEPI: 1
- 应助: 101 (高中生)
- 金币: 12710.8
- 红花: 8
- 沙发: 35
- 帖子: 7496
- 在线: 1516小时
- 虫号: 293006
- 注册: 2006-11-04
- 性别: GG
- 专业: 药剂学
2楼2012-08-15 14:52:27
泡泡-211
至尊木虫 (知名作家)
- PhEPI: 1
- 应助: 101 (高中生)
- 金币: 12710.8
- 红花: 8
- 沙发: 35
- 帖子: 7496
- 在线: 1516小时
- 虫号: 293006
- 注册: 2006-11-04
- 性别: GG
- 专业: 药剂学
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与，应助指数 +1
jinmei7020: 金币+10, ★★★很有帮助 2012-08-16 08:54:12
感谢参与，应助指数 +1
jinmei7020: 金币+10, ★★★很有帮助 2012-08-16 08:54:12
|
应该是Aspirin Delayed-Release Tablets » Aspirin Delayed-Release Tablets contain not less than 95.0 percent and not more than 105.0 percent of the labeled amount of aspirin (C9H8O4 ). Packaging and storage— Preserve in tight containers. Labeling— The label indicates that the Tablets are enteric-coated. USP Reference standards 11 — USP Aspirin RS USP Salicylic Acid RS Identification— A: Crush 1 Tablet, boil it with 50 mL of water for 5 minutes, cool, and add 1 or 2 drops of ferric chloride TS: a violet-red color is produced. B: Infrared Absorption 197K —Prepare the test specimen as follows. Shake a quantity of finely powdered Tablets, equivalent to about 500 mg of aspirin, with 10 mL of alcohol for several minutes. Centrifuge the mixture. Pour off the clear supernatant, and evaporate it to dryness. Dry the residue in vacuum at 60 for 1 hour. Dissolution 711 — Proceed as directed for Procedure for Method B under Apparatus 1 and Apparatus 2, Delayed-Release Dosage Forms. Apparatus 1: 100 rpm. Time: 90 minutes, for Buffer stage. Diluent— Prepare a mixture of 0.1 N hydrochloric acid and 0.20 M tribasic sodium phosphate (3:1), and adjust, if necessary, with 2 N hydrochloric acid or 2 N sodium hydroxide to a pH of 6.8 ± 0.05. Procedure— Determine the amount of C9H8O4 dissolved by determining UV absorbances at the wavelength of the isosbestic point of aspirin and salicylic acid (about 280 nm in the Acid stage, and about 265 nm in the Buffer stage), using a filtered portion of the solution under test, diluted, if necessary, with 0.1 N hydrochloric acid (analyzing the Acid stage) and with Diluent (analyzing the Buffer stage), in comparison with a Standard solution having a known concentration of USP Aspirin RS in the same Medium. Uniformity of dosage units 905 : meet the requirements. Limit of free salicylic acid— Mobile phase and Diluting solution— Prepare as directed in the Assay. Standard solution— Dissolve an accurately weighed quantity of USP Salicylic Acid RS in the Standard preparation prepared as directed in the Assay, to obtain a solution having a known concentration of about 0.015 mg of salicylic acid per mL. Test solution— Use the Stock solution, prepared as directed for Assay preparation in the Assay. Chromatographic system— Use the Chromatographic system described in the Assay. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the relative retention times are about 0.7 for salicylic acid and 1.0 for aspirin; the resolution, R, between salicylic acid and aspirin is not less than 2.0; and the relative standard deviation of the salicylic acid peak responses is not more than 4.0%. Procedure— Proceed as directed for Procedure in the Assay. Calculate the percentage of salicylic acid (C7H6O3 ) in the portion of Tablets taken by the formula: 2000(C/ Q A )( r U / r S ) in which C is the concentration, in mg per mL, of USP Salicylic Acid RS in the Standard solution; Q A is the quantity, in mg, of aspirin (C9H8O4 ) in the portion of Tablets taken, as determined in the Assay; and r U and r S are the peak responses of the salicylic acid peaks obtained from the Test solution and the Standard solution, respectively: not more than 3.0% is found. Assay— Mobile phase— Dissolve 2 g of sodium 1-heptanesulfonate in a mixture of 850 mL of water and 150 mL of acetonitrile, and adjust with glacial acetic acid to a pH of 3.4. Diluting solution— Prepare a mixture of acetonitrile and formic acid (99:1). Standard preparation— Dissolve an accurately weighed quantity of USP Aspirin RS in Diluting solution to obtain a solution having a known concentration of about 0.5 mg per mL. Assay preparation— Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed quantity of the powder, equivalent to about 100 mg of aspirin, to a suitable container. Add 20.0 mL of Diluting solution and about 10 glass beads. Shake vigorously for about 10 minutes, and centrifuge (Stock solution). Quantitatively dilute an accurately measured volume of the Stock solution with 9 volumes of Diluting solution (Assay preparation). Retain the remaining portion of Stock solution for the test for Limit of free salicylic acid. Chromatographic system (see Chromatography 621 )— The liquid chromatograph is equipped with a 280-nm detector and a 4.0-mm × 30-cm column containing packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not greater than 2.0; and the relative standard deviation is not more than 2.0%. Procedure— Separately inject equal volumes (about 10 μL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of aspirin (C9H8O4 ) in the portion of Tablets taken by the formula: 200C ( r U / r S ) in which C is the concentration, in mg per mL, of USP Aspirin RS in the Standard preparation; and r U and r S are the peak responses of the aspirin peaks obtained from the Assay preparation and the Standard preparation, respectively. Auxiliary Information— Please check for your question in the FAQs before contacting USP. |
3楼2012-08-15 14:56:44
40